Immobilised growth factors for scalable cell therapy manufacturing platforms
Regenerative medicine has the potential to establish or restore normal function in defective tissues and organs. The realisation of such therapies is restricted due to costs, lack of scalability and inefficient manufacturing process controls. A major contributor to cost is the use of expensive growt...
Saved in:
| Main Author: | |
|---|---|
| Format: | Default Thesis |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2134/27912 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|